Loading data for LFMDP — first visit, this takes a few seconds.
LifeMD Inc. (LFMDP)
NasdaqGM: LFMDP
· Echtzeitkurs · USD
23.40
+0.15 (0.65%)
Zum Schluss: Aug 18, 2026, 9:42 AM
LifeMD Inc. (LFMDP) Stock Price, Analysis & Data
0.65% (1D)
| Geld | 23.45 |
| Marktkapitalisierung | n/a |
| Umsatz (TTM) | 191.59 Mio |
| Nettogewinn (TTM) | -24.87 Mio |
| Beta | 2.06 |
| EPS (ttm) | -2.26 |
| KGV (TTM) | n/a |
| Forward-KGV | n/a |
| KBV (TTM) | 74.05 |
| KUV (TTM) | n/a |
| Earnings Date | n/a |
| Brief | 24 |
| Volumen | 436 |
| Ø Vol. (20D) | 2,206 |
| Eröffnung | 23.40 |
| Vortagesschluss | 23.25 |
| Tagesspanne | 23.40 - 23.40 |
| 52-Wk Range | 18.50 - 24.20 |
| Analyst | n/a |
| Kursziel | n/a |
| Dividenden | $2.22 (9.54%) |
| Ex-Dividenden-Datum | 2. Juli 2026 |
Über LFMDP
LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and p...
Branche Health Information Services
Sektor Healthcare
IPO Datum Oct 5, 2021
Mitarbeiter 347
Börse NasdaqGM
Tickersymbol LFMDP
Website https://lifemd.com
Finanzielle Entwicklung
Im Jahr 2025 betrug der Umsatz von LifeMD 194.06 Mio, ein Anstieg von 25.34% im Vergleich zum Vorjahr (154.82 Mio). Der Gewinn lag bei 14.35 Mio, ein Rückgang von -167.05 %.
Finanzberichte
Seite 1 von 2